Health News Releases

  • Today March 21
December 01, 2022 09:50
ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
ANANDA Scientific Inc., a research focused bio-pharmaceutical company today announced approval by the US Food and Drug Administration (FDA) of the IND application for a clinical trial evaluating Nanth
December 01, 2022 09:40
New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery
Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the st
December 01, 2022 09:40
ViiV Healthcare Unveils a New Global Study Revealing Three Quarters of People Believe There Are Still Negative Perceptions When It Comes to People Living With HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from a perceptions survey which unveils a widespread gap in
November 30, 2022 10:20
Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) will manufacture and supply intermediates to Shionogi & Co., Ltd. (Headquarters: Chuo-ku, Osaka; Chief Executive Officer:
November 30, 2022 10:10
Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to inves
November 29, 2022 13:20
LevitasBio Strengthens its C-Suite
LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of Global
November 28, 2022 16:05
Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients
Regulatory News: CSL Vifor and Fresenius Kabi today announced that China’s National Medical Products Administration (NMPA) has approved Ferinject®, a preparation for intravenous iron therapy for th
November 28, 2022 14:00
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant A
November 25, 2022 15:35
Iron Deficiency Day 2022: CSL Vifor calls to take iron seriously
Regulatory News: Tomorrow is Iron Deficiency Day. For the eighth consecutive year, CSL Vifor is supporting a growing alliance of international organizations including the Heart Failure Policy Netwo
November 23, 2022 16:50
Takeda’s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review of the Biologics License Application (BLA) for TAK-003, the company
November 22, 2022 13:45
Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More Medicines to Patients Faster
Merck, a leading science and technology company, today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity. To achieve the goal of introduc
November 21, 2022 16:10
DentalMonitoring Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology
DentalMonitoring SAS, the inventor of the world’s first AI-driven remote monitoring and analysis solution for orthodontics, today announced that it has filed a patent infringement lawsuit against Alig
November 21, 2022 13:45
Monrol and FutureChem Announced a Clinical Supply Partnership
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) is delighted to announce that it has reached an agreement in principal with FutureChem based in Seoul, South Korea, a radiopharmaceutical company, for t
November 21, 2022 11:55
Phase 3 Trial of ICLUSIG® (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US
Takeda (TSE:4502/NYSE:TAK) today announced that the randomized, Phase 3 PhALLCON trial met its primary endpoint, demonstrating that adult patients with newly-diagnosed Philadelphia chromosome-positive
DEXLEVO at AMWC JAPAN: a Successful Debut
November 21, 2022 09:45
DEXLEVO at AMWC JAPAN: a Successful Debut
DEXLEVO, a company specializing in beauty medical devices, attended the Aesthetic and Anti-Aging Medicine World Congress (AMWC Japan) held for the first time in Japan. AMWC is one of the world’s three
November 18, 2022 16:40
The New England Journal of Medicine and NEJM Group partner with Wolters Kluwer to expand global reach of leading journals
Wolters Kluwer Health and NEJM Group have entered into an exclusive partnership to ensure that more researchers and clinicians around the world can access the growing family of NEJM Group journals. Bu
November 18, 2022 16:20
ImmunoMet Therapeutics Announces First Patient Dosed in a Phase 1b Trial of IM156 in Pancreatic Cancer
ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-cancer and anti-fibrotic therapies, today announces that the first patient has been dose
November 18, 2022 15:30
Neuraptive Therapeutics, Inc. Announces Appointment of Leading Industry Executive, Dr. Robert R. Ruffolo as New Director to the Board
Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by nerve injuries,
GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity
November 18, 2022 14:30
GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesne
November 16, 2022 11:20
Medidata Launches Rave Companion, the First Scalable Solution for Automating EHR Data Entry into Rave EDC
Medidata, a Dassault Systèmes company, today announced plans to launch Rave Companion, an innovative, scalable, patent pending technology helping clinical trial sites save time and reduce errors in tr
The GICELL presents preclinical data of T.O.P. NK at SITC in Boston, MA, USA. (Photo provided by GIC
November 16, 2022 11:06
GICELL Proves Excellent Anti-tumor Efficacy in Various Solid Tumor-bearing Animal Model
GICELL announced the data from the preclinical studies on T.O.P. NK (Tumor targeting, Optimally Primed NK), an allogeneic NK cell therapy which had been presented at the Society for Immunotherapy of C
November 15, 2022 14:45
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea’s Leading Bone Densitometry Platform
MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for assessing bone health, today announced that its novel method for enhancing osteopo
November 15, 2022 12:08
TMD LAB Starts Joint Research on Shape-memory Polymer Materials with US NIST
TMD LAB (CEO Hak-Joon Sung) and the National Institute of Standards and Technology (NIST) under the U.S. Department of Commerce are starting joint research on the properties of SMP materials. TMD L
November 14, 2022 17:35
World-First Inhaled COVID-19 Vaccine, Developed in Partnership Between Aerogen® and CanSinoBIO, First Public Booster Immunization in China.
Late in 2021, Aerogen® (Galway, Ireland) and CanSinoBIO (SSE: 688185, HKEX: 06185) (Tianjin, China) announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s R
November 11, 2022 22:00
Ur24Technology Launches New and Unique ‘TrueClr’ External Catheter Line
Ur24Technology Inc., a privately held medical device company, has launched the TrueClr catheter product line - offering physicians, nurses and patients a choice that will eliminate catheter-associated
November 11, 2022 16:25
European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Infection And/or Disease That Are Refractory (With or Without Resistance) to One or More Prior Therapies
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) has granted Marketing Authorization for LIVTENCITYTM (maribavir) for the treatment of cytomegalovirus (CMV) infection and/o
November 11, 2022 15:40
Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
Kirin Holdings Company, Limited (Kirin Holdings) and Kao Corporation (Kao) will participate in the “Wakayama Health Promotion Study” cohort study[*1] led by Wakayama Medical University and compiled by
Top US board-certified plastic surgeons were invited to Moonlight Sylfirm X Global Symposium 2022, a
November 11, 2022 10:59
RF Micro-needling Device, Sylfirm X Recognized by Top US Aesthetic Dermatologists
VIOL Co., Ltd hosted the first global event called ‘Moonlight Sylfirm X Global Symposium 2022’ on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium invited renowned domestic aesthetic d
November 10, 2022 11:58
Dong-A ST Out License NESP® Biosimilar DA-3880 to Polifarma of Türkiye
Dong-A ST (Min Young Kim, President and CEO) (KRX: 170900) announced that they signed an exclusive license-out and supply agreement on November 4, 2022, with Polifarma (Mehmet Asri, CEO) for NESP® bio
November 08, 2022 14:10
Merck, Synergis & IPS Present on Engineering Document Management for Simplified Compliance & Validation
Synergis Software, a global leader in engineering document management and workflow solutions, today announced they will participate in a collaborative, live panel with leaders from Merck, known as MSD
November 08, 2022 11:30
LevitasBio Completes Series C Financing
LevitasBio, Inc., www.levitasbio.com, a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to ad
November 07, 2022 11:50
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (CKD).[1,2] When treated wi
November 07, 2022 10:10
Aster Guardians Global Nursing Award 2023 worth $250,000 to be held in London
Aster DM Healthcare, one of the largest integrated healthcare providers in GCC and India, has announced London as the next destination for Aster Guardians Global Nursing Award 2023 ceremony. The award
November 04, 2022 15:00
SINOVAC Varicella Vaccine Prequalified by WHO
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it received prequalification from the World Health Orga
November 03, 2022 16:35
Seven pharma CEOs announce new joint action to accelerate net zero healthcare
CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi today announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of n
November 03, 2022 13:50
CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1
CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx[*1] sol
November 02, 2022 13:10
OUI Inc., the Japanese Startup of a Smartphone-based Ophthalmic Diagnostic Medical Device, Wins First Prize at AEA2022 Innovation Awards
The Asian Entrepreneurship Award 2022 event (AEA2022) was held fully online from Wednesday, October 26th to Thursday, October 27th with the participation of 24 tech startups selected from Asian countr
November 01, 2022 14:30
Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence
Eucure Biopharma, a China-based clinical-stage biotechnology company focused on the development of antibody therapeutics, announced today that it has entered into a collaborative agreement with ISU AB
October 31, 2022 10:40
SINOVAC to Showcase Products at CPHI Frankfurt
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of the wo
CLECELL and CancerFree Biotech logo
October 28, 2022 16:54
CLECELL and CancerFree Biotech Jointly Develop Anti-cancer Drug Sensitivity Testing Services
3D bioprinting company CLECELL announced that it had signed an MoU with Taiwanese bio company CancerFree Biotech for the commercialization of an organoid-based anti-cancer drug sensitivity test. Si
October 28, 2022 15:30
SYNLAB and Microba reinforce their combined expertise and expand strategic agreement on advanced gut microbiome test myBIOME
SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut microbiomes, have expanded their
October 28, 2022 14:40
Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2022 (period ended September 30, 2022), upgrading reported and core forecasts and free cash flow outloo
October 28, 2022 10:45
Medisca to Open New Plattsburgh, NY Facility Exceeding Rigorous Quality and Employee Safety Standards
Medisca, a global company offering pharmaceutical compounding products and services, mixing technology, manufacturing, education services and more, announces plans to lease a standalone 60,000 square
October 28, 2022 10:00
Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
Medidata, a Dassault Systèmes company, and Boehringer Ingelheim today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The new agreement extends the u
October 26, 2022 17:25
Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
Merck, a leading science and technology company, today announced it will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),
October 26, 2022 16:57
Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment
Merck, a leading science and technology company, today announced findings which demonstrated that annualized relapse rates (ARR) remained low and Expanded Disability Status Scale (EDSS) scores were st
October 25, 2022 16:55
Ferring Presents Seven New Analyses at ACG 2022 for RBX2660, Its Investigational Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting of seven analyses for RBX2660, an investigational microbiota-b
October 25, 2022 14:55
Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair
Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerv
October 25, 2022 13:30
DentalMonitoring Now Offers Smart STL[*] Powered by AI-driven Technology
DentalMonitoring now offers Smart STL[*] powered by AI-driven technology. The company brings the only platform in the oral healthcare industry capable of creating updated STL files 100% remotely[*]. T
October 25, 2022 10:50
Urethral Stricture: BEES-HAUS Cell Therapy Approach Proven With Cell Engraftment by Urologists of Edogawa Hospital, Japan, Holds Potential to Prevent Recurrence.
Urethral stricture, blocking the passage of urine from the bladder in men, could be solved by BEES-HAUS cell therapy, a novel autologous buccal mucosal cell-based approach as reported by Dr. Akio Hori
25 per page50 per page75 per page100 per page